For luminal A breast cancer, we observed that genes associated with favourable prognosis—including key regulators of glucose metabolism HK3, LDHAL6A, apoptosis regulator PRKCB, and alcohol dehydrogenase ADH6—are not directly targeted by current treatments. The gene discussed is HK3; the disease is breast cancer.